CORRELATION OF GENOMIC ANALYSIS BY MYAML™ WITH IN VITRO HIGH THROUGHPUT DRUG SENSITIVITY TESTING IN NEW DIAGNOSIS AND RELAPSED ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Becker, P. S. [1 ,2 ]
Schmitt, M. [3 ]
Loeb, L. [4 ]
Gu, W. [5 ]
Wei, Q. [5 ]
Xie, Z. [6 ]
Carson, A. [6 ]
Martins, T. [7 ]
Blau, C. A. [7 ,8 ]
Oehler, V. [2 ]
Yeung, K. Y. [9 ]
机构：
[1] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98195 USA
[3] Univ Washington, Hematol & Med Oncol, Seattle, WA 98195 USA
[4] Univ Washington, Pathol, Seattle, WA 98195 USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Invivoscribe, San Diego, CA USA
[7] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
[8] Univ Washington, Ctr Canc Innovat, Seattle, WA 98195 USA
[9] Univ Washington, Inst Technol, Tacoma, WA USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E919
引用
收藏
页码：365 / 366
页数：2
相关论文
共 50 条
  • [41] Genomic profile at diagnosis by targeted high throughput sequencing, and real-world clinical outcomes in patients diagnosed with acute myeloid leukemia at a tertiary care cancer center.
    Radhakrishnan, Vivek Sulekha
    Bhaduri, Arunima
    Arora, Neeraj
    Nair, Reena
    Bhattacharya, Shreya
    Sanyal, Somanka
    Veldore, Vidya
    Parihar, Mayur
    Bhave, Saurabh Jayanth
    Kumar, Jeevan
    Ramprasad, V. L.
    Mishra, Deepak Kumar
    Chandy, Mammen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Genomic profiling and directed ex vivo drug analysis of an unclassifiable myelodysplastic/myeloproliferative neoplasm progressing into acute myeloid leukemia
    Hyrenius-Wittsten, Axel
    Sturesson, Helena
    Bidgoli, Mahtab
    Jonson, Tord
    Ehinger, Mats
    Lilljebjorn, Henrik
    Scheding, Stefan
    Andersson, Anna K.
    GENES CHROMOSOMES & CANCER, 2016, 55 (11): : 847 - 854
  • [43] Difference in FLT3 Mutational Status between Diagnosis and Relapsed/Refractory Acute Myeloid Leukemia: A Meta-Analysis
    Silva, Lais Teixeira
    Campos, Camilla C.
    Salvino, Marco Aurelio
    BLOOD, 2020, 136
  • [44] High dose cytarabine and cyclophosphamide (hAC) regimen for relapsed or refractory acute myeloid leukemia (AML): a retrospective monocentric analysis
    Fix, P.
    Fricke, H-J
    Spies-Weisshart, B.
    La Rosee, P.
    Hochhaus, A.
    Scholl, S.
    ONKOLOGIE, 2010, 33 : 138 - 139
  • [45] Stromal Cell Supported High-Throughput Drug Testing Of Primary Leukemia Cells For Comprehensive Assessment Of Sensitivity To Novel Therapies
    Karjalainen, Riikka
    Pemovska, Tea
    Yadav, Bhagwan
    Majumder, Muntasir Mamun
    Kontro, Mika
    Porkka, Kimmo
    Kallioniemi, Olli
    Aittokallio, Tero
    Wennerberg, Krister
    Heckman, Caroline A.
    BLOOD, 2013, 122 (21)
  • [46] High-resolution SNP array profiting of relapsed acute leukemia identifies genomic abnormalities distinct from those present at diagnosis
    Mullighan, Charles G.
    Radtke, Ina
    Ma, Jing
    Shurtleff, Sheila A.
    Downing, James R.
    BLOOD, 2007, 110 (11) : 76A - 76A
  • [47] A novel high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory acute myeloid leukemia (AML): Proof of concept and clinical implementation of precision medicine
    Shum, David
    Santos, Ruth
    Heaney, Mark
    Brentjens, Renier
    Maslak, Peter
    Rosenblat, Todd
    Jurcic, Joseph
    Djaballah, Hakim
    Frattini, Mark G.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [48] Optical Genome Mapping Combined with High-Throughput Sequencing Is Effective for the Diagnostic and Prognostic Genomic Classification of Acute Myeloid Leukemia and Myelodysplastic Neoplasms
    Bris, Yannick L. E.
    Madeuf, Romain
    Godon, Catherine
    Pichon, Olivier
    Peterlin, Pierre
    Garnier, Alice
    Chevallier, Patrice
    Bouzy, Simon
    Eveillard, Marion
    Bene, Marie-Christine
    Theisen, Olivier
    Farahani, Faeseh Vasheghani
    BLOOD, 2023, 142
  • [49] Identification of Personalized Therapeutic Strategies and Associated Biomarkers in Adult Acute Myeloid Leukemia Using a Functional Drug Sensitivity and Resistance Testing Platform
    Pemovska, T.
    Yadav, B.
    Kulesskiy, E.
    Kontro, M.
    Heckman, C.
    Knowles, J.
    Porkka, K.
    Aittokallio, T.
    Kallioniemi, O.
    Wennerberg, K.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 142 - 143
  • [50] Single-cell analysis of mutational heterogeneity in acute myeloid leukemia tumors with high-throughput droplet microfluidics
    Eastburn, Dennis J.
    Pellegrino, Maurizio
    Sciambi, Adam
    Treusch, Sebastian
    Xu, Liwen
    Durruthy-Durruthy, Robert
    Gokhale, Kaustubh
    Jacob, Jose
    Chen, Tina X.
    Oldham, William
    Matthews, Jairo
    Kantarjian, Hagop
    Futreal, Andrew
    Patel, Keyur
    Jones, Keith W.
    Zehnder, James L.
    Takahashi, Koichi
    CANCER RESEARCH, 2018, 78 (13)
12345